Symposium 7: Nutrition in inflammatory bowel disease Dietary and nutritional considerations for inflammatory bowel disease

Proceedings of the Nutrition Society

Volumn 70, Issue 3, 2011, Pages 329-335

  Lomer, Miranda C E ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Crohn's disease; Diet; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

DISACCHARIDE; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYOL; PREBIOTIC AGENT; PROBIOTIC AGENT;

ABDOMINAL PAIN; ANEMIA; BLOATING; CONFERENCE PAPER; CROHN DISEASE; DIARRHEA; DIETARY INTAKE; DISEASE COURSE; FERMENTATION; FIBER; FLATULENCE; FLUID TRANSPORT; HUMAN; INTESTINE FLORA; INTESTINE OBSTRUCTION; INTESTINE STRICTURE; MALNUTRITION; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL DEFICIENCY; OSMOSIS; OSTEOPOROSIS; PREVALENCE; QUALITY OF LIFE; REMISSION; RISK FACTOR; ULCERATIVE COLITIS; WEIGHT REDUCTION; BACTERIUM; CARBOHYDRATE DIET; DIET; DIET THERAPY; ENTERITIS; INTESTINE; METABOLISM; MICROBIOLOGY; REVIEW;

BACTERIA (MICROORGANISMS);

BACTERIA; DEFICIENCY DISEASES; DIET; DIETARY CARBOHYDRATES; FERMENTATION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL OBSTRUCTION; INTESTINES; MALNUTRITION; WEIGHT LOSS;

EID: 80054955786     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665111000097     Document Type: Conference Paper

References (89)

1. Van Assche G, Dignass A, Panes J, et al. (2010) The second European evidence-based consensus on the diagnosis and management of Crohns disease: Definitions and diagnosis. J Crohns Colitis 4, 7-27
2. Stange EF, Travis SP, Vermeire S, et al. (2008) European evidence-based consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis 2, 1-23
3. Xavier RJ & Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434
4. Scaldaferri F & Fiocchi C (2007) Inflammatory bowel disease: Progress and current concepts of etiopathogenesis. J Dig Dis 8, 171-178
5. Chapman-Kiddell CA, Davies PS, Gillen L, et al. (2010) Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis 16, 137-151
6. Jayanthi V, Probert CS, Pinder D, et al. (1992) Epidemiology of Crohns disease in Indian migrants and the indigenous population in Leicestershire. Q J Med 82, 125-138
7. Molodecky NA & Kaplan GG (2010) Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol 16, 339-346
8. Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134, 577-594
9. Karlinger K, Gyorke T, Mako E, et al. (2000) The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 35, 154-167
10. Molodecky NA, Panaccione R, Ghosh S, et al. (2010) Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis Epublication ahead of print
11. Porro GB & Panza E (1985) Smoking, sugar, and inflammatory bowel disease. Br Med J 291, 971-972
12. Reif S, Klein I, Lubin F, et al. (1997) Pre-illness dietary factors in inflammatory bowel disease. Gut 40, 754-760
13. Sakamoto N, Kono S, Wakai K, et al. (2005) Dietary risk factors for inflammatory bowel disease: A multicenter casecontrol study in Japan. Inflamm Bowel Dis 11, 154-163
14. Thornton JR, Emmett PM & Heaton KW (1979) Diet and Crohns disease: Characteristics of the pre-illness diet. Br Med J 2, 762-764
15. Tragnone A, Valpiani D, Miglio F, et al. (1995) Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 7, 47-51
16. Gassull MA (2001) Dietary fat intake and inflammatory bowel disease. Curr Gastroenterol Rep 3, 358-361
17. Belluzzi A, Brignola C, Campieri M, et al. (1996) Effect of an enteric-coated fish-oil preparation on relapses in Crohns disease. N Engl J Med 334, 1557-1560
18. Trebble TM, Stroud MA, Wootton SA, et al. (2005) Highdose fish oil and antioxidants in Crohns disease and the response of bone turnover: A randomised controlled trial. Br J Nutr 94, 253-261
19. Shoda R, Matsueda K, Yamato S, et al. (1996) Epidemiologic analysis of Crohn disease in Japan: Increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 63, 741-745
20. Epidemiological Group of the Research Committee of IBD in Japan (1994) Dietary and other risk factors of ulcerative colitis. A case-control study in Japan. Epidemiology group of the research committee of inflammatory Bowel disease in Japan. J Clin Gastroenterol 19, 166-171
21. Hart AR, Luben R, Olsen A, et al. (2008) Diet in the aetiology of ulcerative colitis: A European prospective cohort study. Digestion 77, 57-64
22. Tjonneland A, Overvad K, Bergmann MM, et al. (2009) Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: A nested case-control study within a European prospective cohort study. Gut 58, 1606-1611
23. Jowett SL, Seal CJ, Pearce MS, et al. (2004) Influence of dietary factors on the clinical course of ulcerative colitis: A prospective cohort study. Gut 53, 1479-1484
24. Jantchou P, Morois S, Clavel-Chapelon F, et al. (2010) Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol 105, 2195-2201
25. Persson PG, Ahlbom A & Hellers G (1992) Diet and inflammatory bowel disease: A case-control study. Epidemiology 3, 47-52
26. Lomer MC, Thompson RP & Powell JJ (2002) Fine and ultrafine particles of the diet: Influence on the mucosal immune response and association with Crohns disease. Proc Nutr Soc 61, 123-130
27. Lomer MC, Grainger SL, Ede R, et al. (2005) Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohns disease. Eur J Gastroenterol Hepatol 17, 377-384
28. Bannerman E, Davidson I, Conway C, et al. (2001) Altered subjective appetite parameters in Crohns disease patients. Clin Nutr 20, 399-405
29. Gassull MA & Cabre E (2001) Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 4, 561-569
30. IBD Standards Working Group Quality Care: Service standards for the healthcare of people who have inflammatory bowel disease (IBD) 2009. http://www.ibdstandards.org.uk/uploaded-files/IBDstandards.pdf (accessed 6 May 2009)
31. Lomer MCE (2009) National UK audits in inflammatory bowel disease (IBD) highlight a deficit of dietitians in gastroenterology: A priority for improvement supported by national IBD standards. J Hum Nutr Diet 22, 287-289
32. Gourgey R, Whelan K & Lomer MCE (2009) Dietetic assessment and management of enteral nutrition in patients with Crohns disease: Current practice in the United Kingdom. J Hum Nutr Diet (In the Press)
33. UK IBD Audit Steering Group IBD audit (2006) National results for the organisation and process of IBD care in the UK 2007. http://www.rcplondon.ac.uk/ clinical-standards/ceeu/Current-work/Documents/ceeu-uk-ibd-audit-2006.pdf (accessed 6 May 2009)
34. UK IBD Audit Steering Group IBD audit (2008) National results for the organisation and process of IBD care in the UK (2009). http://www.rcplondon.ac. uk/clinical-standards/ceeu/Current-work/Documents/UK-IBD-Audit-2nd-Round- Full-National-Report-Appendices.pdf (accessed 6 May 2009)
35. Prince A, Moose A, Whelan K, et al. (2010) Patients with Crohns disease and ulcerative colitis have similar food and nutrition problems and share views on research priorities in inflammatory bowel disease. J Hum Nutr Diet 23, 460-461
36. Lomer MC, Kodjabashia K, Hutchinson C, et al. (2004) Intake of dietary iron is low in patients with Crohns disease: A case-control study. Br J Nutr 91, 141-148
37. Vagianos K, Bector S, McConnell J, et al. (2007) Nutrition assessment of patients with inflammatory bowel disease. J Parenter Enteral Nutr 31, 311-319
38. Geerling BJ, Stockbrugger RW & Brummer RJ (1999) Nutrition and inflammatory bowel disease: An update. Scand J Gastroenterol Suppl 230, 95-105
39. Valentini L, Schaper L, Buning C, et al. (2008) Malnutrition and impaired muscle strength in patients with Crohns disease and ulcerative colitis in remission. Nutrition 24, 694-702
40. Mijac DD, Jankovic GL, Jorga J, et al. (2010) Nutritional status in patients with active inflammatory bowel disease: Prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med 21, 315-319
41. Geerling BJ, Badart-Smook A, Stockbrugger RW, et al. (1998) Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 67, 919-926
42. OSullivan M & OMorain C (2006) Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 20, 561-573
43. Bernstein CN, Blanchard JF, Leslie W, et al. (2000) The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 133, 795-799
44. van Staa TP, Cooper C, Brusse LS, et al. (2003) Inflammatory bowel disease and the risk of fracture. Gastroenterology 125, 1591-1597
45. Tilg H, Moschen AR, Kaser A, et al. (2008) Gut, inflammation and osteoporosis: Basic and clinical concepts. Gut 57, 684-694
46. Lewis NR & Scott BB (2007) Guidelines for osteoporosis in inflammatory bowel disease and coeliac disease 2007. http://www.bsg.org.uk/ clinical-guidelines/ibd/guidelines-forosteoporosis- in-inflammatory-bowel- disease-and-coeliacdisease. html (accessed 5 February 2011)
47. Dignass A, Assche GV, Lindsay JO, et al. (2010) The second European evidence-based consensus on the diagnosis and management of Crohns disease: Current management. J Crohns Colitis 4, 28-62
48. Compston J (2003) Osteoporosis in inflammatory bowel disease. Gut 52, 63-64
49. Kulnigg S & Gasche C (2006) Systematic review: Managing anaemia in Crohns disease. Aliment Pharmacol Ther 24, 1507-1523
50. Gasche C, Lomer MC, Cavill I, et al. (2004) Iron, anaemia, and inflammatory bowel diseases. Gut 53, 1190-1197
51. Gasche C, Berstad A, Befrits R, et al. (2007) Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 13, 1545-1553
52. Stein J, Hartmann F & Dignass AU (2010) Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 7, 599-610
53. Yakut M, Ustun Y, Kabacam G, et al. (2010) Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med 21, 320-323
54. Driscoll RH Jr & Rosenberg IH (1978) Total parenteral nutrition in inflammatory bowel disease. Med Clin North Am 62, 185-201
55. Ostro MJ, Greenberg GR & Jeejeebhoy KN (1985) Total parenteral nutrition and complete bowel rest in the management of Crohns disease. J Parenter Enteral Nutr 9, 280-287
56. Griffiths AM, Ohlsson A, Sherman PM, et al. (1995) Metaanalysis of enteral nutrition as a primary-treatment of active Crohns-disease. Gastroenterology 108, 1056-1067
57. Zachos M, Tondeur M & Griffiths AM (2007) Enteral nutritional therapy for induction of remission in Crohns disease. Cochrane Database Syst Rev 3, CD000542
58. Bamba T, Shimoyama T, Sasaki M, et al. (2003) Dietary fat attenuates the benefits of an elemental diet in active Crohns disease: A randomized, controlled trial. Eur J Gastroenterol Hepatol 15, 151-157
59. Gassull MA, Fernandez-Banares F, Cabre E, et al. (2002) Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohns disease: Results of a double blind randomised multicentre European trial. Gut 51, 164-168
60. Gorard DA (2003) Enteral nutrition in Crohns disease: Fat in the formula. Eur J Gastroenterol Hepatol 15, 115-118
61. Leiper K, Woolner J, Mullan MM, et al. (2001) A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohns disease. Gut 49, 790-794
62. Giaffer MH, North G & Holdsworth CD (1990) Controlled trial of polymeric versus elemental diet in treatment of active Crohns disease. Lancet 335, 816-819
63. Fell JM, Paintin M, Arnaud-Battandier F, et al. (2000) Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohns disease. Aliment Pharmacol Ther 14, 281-289
64. Yamamoto T, Nakahigashi M, Umegae S, et al. (2007) Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohns disease: A prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther 25, 67-72
65. Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M, et al. (1993) Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am J Gastroenterol 88, 227-232
66. Riordan AM, Hunter JO, Cowan RE, et al. (1993) Treatment of active Crohns disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 342, 1131-1134
67. Woolner JT, Parker TJ, Kirby GA, et al. (1998) The development and evaluation of a diet for maintaining remission in Crohns disease. J Hum Nutr Diet 11, 1-11
68. Akobeng AK & Thomas AG (2007) Enteral nutrition for maintaenance of remission in Crohns disease. Cochrane Database Syst Rev 3, CD005984
69. Ballegaard M, Bjergstrom A, Brondum S, et al. (1997) Selfreported food intolerance in chronic inflammatory bowel disease. Scand J Gastroenterol 32, 569-571
70. Meier R & Gassull M (2004) Consensus recommendations on the effects and benefits of fibre in clinical practice. Clin Nutr Suppl 1, 73-80
71. Lomer MCE (2011) Dietary considerations in IBD. In Inflammatory Bowel Disease Nursing, pp. 139-159 [K Whayman, J Duncan and M. OConnor, editors]. Quay Books: London
72. Raouf AH, Hildrey V, Daniel J, et al. (1991) Enteral feeding as sole treatment for Crohns-disease - controlled trial of whole protein upsilon-amino acid based feed and a casestudy of dietary challenge. Gut 32, 702-707
73. Hedin C, Whelan K & Lindsay JO (2007) Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: A review of clinical trials. Proc Nutr Soc 66, 307-315
74. Mimura T, Rizzello F, Helwig U, et al. (2004) Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53, 108-114
75. Gionchetti P, Rizzello F, Venturi A, et al. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 119, 305-309
76. Gionchetti P, Rizzello F, Helwig U, et al. (2003) Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial. Gastroenterology 124, 1202-1209
77. Kruis W, Schutz E, Fric P, et al. (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11, 853-858
78. Kruis W, Fric P, Pokrotnieks J, et al. (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53, 1617-1623
79. Rembacken BJ, Snelling AM, Hawkey PM, et al. (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial. Lancet 354, 635-639
80. Butterworth AD, Thomas AG & Akobeng AK (2008) Probiotics for induction of remission in Crohns disease. Cochrane Database Syst Rev 3, CD006634
81. Mallon P, McKay D, Kirk S, et al. (2007) Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 4, CD005573
82. Simren M, Axelsson J, Gillberg R, et al. (2002) Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 97, 389-396
83. Shepherd SJ, Parker FC, Muir JG, et al. (2008) Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: Randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 6, 765-771
84. Barrett JS, Gearry RB, Muir JG, et al. (2010) Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 31, 874-882
85. Ong DK, Mitchell SB, Barrett JS, et al. (2010) Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 25, 1366-1373
86. Gearry RB, Irving PM, Barrett JS, et al. (2009) Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease. J Crohns Colitis 3, 8-14
87. Barrett JS & Gibson PR (2007) Clinical ramifications of malabsorption of fructose and other short chain carbohydrates. Pract Gastroenterol 53, 51-65
88. Gibson PR & Shepherd SJ (2010) Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol 25, 252-258
89. Krok KL & Lichtenstein GR (2003) Nutrition in Crohn disease. Curr Opin Gastroenterol 19, 148-153